Clinical trials: Cellular Rejection

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

• Completed
• Age: All ages
• Phase 2
• Results posted

This phase II trial studies pentostatin and donor lymphocyte infusion in preventing graft rejection in patients who have undergone donor stem cell transplant.

Conditions

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Trial name

NCT00096161

Testing

Cyclosporine, Mycophenolate Mofetil, Pentostatin

Where

5 sites in United States, Italy

Volunteers

36 people

Sponsor

Fred Hutchinson Cancer Center